No abstract available
Publication types
-
Case Reports
-
Letter
-
Review
MeSH terms
-
Adult
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / therapeutic use
-
Benzamides
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Follow-Up Studies
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Male
-
Piperazines / adverse effects*
-
Piperazines / therapeutic use
-
Pyrimidines / adverse effects*
-
Pyrimidines / therapeutic use
-
Severity of Illness Index
-
Stevens-Johnson Syndrome / chemically induced*
-
Stevens-Johnson Syndrome / physiopathology
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate